MedTrace Logo

Biomarkers of Endometrial Receptivity

NCT04619524 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 476

Last updated 2026-03-20

No results posted yet for this study

Summary

Analysis of proteins from cervical mucus will be done in patients undergoing infertility treatment (fresh or frozen embryo transfer). Cervical mucus will be analysed for potential new biomarkers of endometrium receptivity. Comparison of the peptide spectrum will be done for the pregnant and not pregnant patients.

Conditions

  • IVF
  • Infertility Treatment
  • Fertility Disorders
  • Embryo Transfer

Interventions

DIAGNOSTIC_TEST

Cervical mucus will be collected from patients undergoing IVF

Patients undergoing hormonal stimulation for IVF will be sampled for cervical mucus.

DIAGNOSTIC_TEST

Cervical mucus will be collected from patients undergoing transfer of cryopreserved embryos

Patients undergoing hormonal substitution for transfer of cryopreserved embryos will be sampled for cervical mucus.

Sponsors & Collaborators

  • University Hospital Olomouc

    collaborator OTHER

  • Brno University Hospital

    collaborator OTHER

  • The Institute of Molecular and Translational Medicine, Czech Republic

    lead OTHER

Principal Investigators

  • Marian Hajduch, MD.PhD. · Palacky University in Olomouc, Faculty of Medicine and Dentristry

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04619524 on ClinicalTrials.gov